OTCMKTS:CBIS - Cannabis Science Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.0610 0.00 (0.00 %)
(As of 05/28/2018 02:45 AM ET)
Previous Close$0.0601
Today's Range$0.06 - $0.0620
52-Week Range$0.0311 - $0.1397
Volume2.95 million shs
Average Volume16.61 million shs
Market Capitalization$190.59 million
P/E RatioN/A
Dividend YieldN/A
Beta-3.5

About Cannabis Science (OTCMKTS:CBIS)

Cannabis Science logoCannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. Its drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, benefits of medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug; and a research collaboration agreement with Dana-Farber Cancer Institute, Inc. to develop and investigate the use of cannabinoids to cure various cancers, as well as with Stellenbosch University to treat chronic pelvic pain associated with pelvic inflammatory disease in women, chronic prostatitis in men, and other chronic pain associated with other indications. The company was formerly known as Gulf Onshore, Inc. and changed its name to Cannabis Science, Inc. in April 2009. The company was incorporated in 1996 and is based in Irvine, California. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc.

Receive CBIS News and Ratings via Email

Sign-up to receive the latest news and ratings for CBIS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryCannabis
SectorMedical
SymbolOTCMKTS:CBIS
CUSIPN/A
Phone+1-888-8890888

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-151,408.60%
Return on EquityN/A
Return on Assets-590.52%

Miscellaneous

EmployeesN/A
Outstanding Shares2,520,000,000

Cannabis Science (OTCMKTS:CBIS) Frequently Asked Questions

What is Cannabis Science's stock symbol?

Cannabis Science trades on the OTCMKTS under the ticker symbol "CBIS."

How were Cannabis Science's earnings last quarter?

Cannabis Science Inc (OTCMKTS:CBIS) released its quarterly earnings results on Tuesday, July, 28th. The company reported $0.00 EPS for the quarter. View Cannabis Science's Earnings History.

Who are some of Cannabis Science's key competitors?

Who are Cannabis Science's key executives?

Cannabis Science's management team includes the folowing people:
  • Mr. Raymond C. Dabney, Co-Founder, Chairman, Chief Exec. Officer and Pres (Age 53)
  • Mr. Benjamin C. K. Tam, CFO, Sec. & Director (Age 66)
  • Mr. Robert James Kane, COO, VP of IR & Director (Age 42)
  • Dr. Allen A. Herman M.B., Ch.B., Ph.D., Chief Medical Officer & Member of Scientific Advisory Board (Age 63)
  • Mr. Mario Lap, Pres of European Operations & Director (Age 66)

Has Cannabis Science been receiving favorable news coverage?

Media coverage about CBIS stock has trended positive recently, according to Accern. The research group ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cannabis Science earned a news sentiment score of 0.46 on Accern's scale. They also assigned press coverage about the company an impact score of 46.14 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Cannabis Science?

Shares of CBIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cannabis Science's stock price today?

One share of CBIS stock can currently be purchased for approximately $0.0610.

How big of a company is Cannabis Science?

Cannabis Science has a market capitalization of $190.59 million.

How can I contact Cannabis Science?

Cannabis Science's mailing address is 19800 Macarthur Blvd Ste 300, IRVINE, CA 92612-2479, United States. The company can be reached via phone at +1-888-8890888.


MarketBeat Community Rating for Cannabis Science (CBIS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  147
MarketBeat's community ratings are surveys of what our community members think about Cannabis Science and other stocks. Vote "Outperform" if you believe CBIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBIS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cannabis Science (OTCMKTS:CBIS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/28/2016 forward)

Earnings

Cannabis Science (OTCMKTS:CBIS) Earnings History and Estimates Chart

Earnings by Quarter for Cannabis Science (OTCMKTS:CBIS)

Cannabis Science (OTCMKTS CBIS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/17/2017Q4 2016$0.01ViewN/AView Earnings Details
7/28/2015Q3 2016($0.0030)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Cannabis Science (OTCMKTS:CBIS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Cannabis Science (OTCMKTS CBIS) Insider Trading and Institutional Ownership History

Insider Trading History for Cannabis Science (OTCMKTS:CBIS)

Cannabis Science (OTCMKTS CBIS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2018Benjamin C.K. TamCFOSell193,626$0.10$19,362.60View SEC Filing  
1/3/2018Robert James KaneCOOSell200,000$0.13$26,000.00View SEC Filing  
12/29/2017Robert James KaneCOOSell200,000$0.10$20,000.00View SEC Filing  
11/30/2017Robert James KaneCOOSell198,820$0.06$11,929.20View SEC Filing  
10/20/2016Robert James KaneCOOSell2,000,000$0.07$140,000.0016,537,665View SEC Filing  
10/19/2016Robert James KaneCOOSell4,000,000$0.04$160,000.0018,537,665View SEC Filing  
10/14/2016Robert James KaneCFOSell1,389,577$0.02$27,791.5421,537,665View SEC Filing  
10/10/2016Robert James KaneCFOSell1,783,475$0.02$35,669.5023,710,717View SEC Filing  
9/13/2016Robert James KaneCFOSell2,000,000$0.01$20,000.0024,710,717View SEC Filing  
5/18/2016Robert James KaneCFOSell503,345$0.02$10,066.9024,210,717View SEC Filing  
5/6/2016Robert James KaneCFOSell300,000$0.02$6,000.0024,714,062View SEC Filing  
3/31/2016Chad Steven JohnsonCOOSell500,000$0.02$10,000.0017,920,323View SEC Filing  
3/29/2016Chad Steven JohnsonCOOSell2,402,000$0.02$48,040.0018,522,323View SEC Filing  
3/21/2016Chad Steven JohnsonCOOSell483,852$0.02$9,677.04922,323View SEC Filing  
3/3/2016Chad Steven JohnsonCOOSell2,188,334$0.01$21,883.343,030,175View SEC Filing  
2/29/2016Chad Steven JohnsonCOOSell4,370,000$0.01$43,700.007,195,509View SEC Filing  
2/19/2016Chad Steven JohnsonCOOSell1,765,300$0.01$17,653.008,259,809View SEC Filing  
12/11/2015Chad Steven JohnsonCOOSell1,646,142$0.02$32,922.849,659,809View SEC Filing  
12/3/2015Chad Steven JohnsonCOOSell769,986$0.02$15,399.7211,305,951View SEC Filing  
12/2/2015Chad Steven JohnsonCOOSell1,852,239$0.02$37,044.7812,075,937View SEC Filing  
8/19/2015Chad Steven JohnsonCOOSell6,500,000$0.03$195,000.003,928,176View SEC Filing  
6/9/2015Chad Steven JohnsonCOOSell1,063,575$0.03$31,907.25View SEC Filing  
4/29/2015Chad Steven JohnsonCOOSell921,333$0.04$36,853.32View SEC Filing  
3/27/2015Chad Steven JohnsonCOOSell1,400,000$0.04$56,000.00View SEC Filing  
3/19/2015Chad Steven JohnsonCOOSell1,262,691$0.05$63,134.55View SEC Filing  
2/4/2015Chad Steven JohnsonCOOSell1,809,914$0.06$108,594.84View SEC Filing  
1/20/2015Chad Steven JohnsonCOOSell255,000$0.07$17,850.00View SEC Filing  
1/14/2015Dh BrayCEOSell1,260,750$0.06$75,645.00View SEC Filing  
1/5/2015Chad Steven JohnsonCOOSell1,600,000$0.07$112,000.00View SEC Filing  
11/20/2014Chad Steven JohnsonCOOSell433,990$0.07$30,379.30View SEC Filing  
11/14/2014Chad Steven JohnsonCOOSell251,110$0.06$15,066.60View SEC Filing  
11/3/2014Chad Steven JohnsonCOOSell400,000$0.09$36,000.00View SEC Filing  
10/31/2014Chad Steven JohnsonCOOSell750,000$0.08$60,000.00View SEC Filing  
2/13/2014Robert MelamedeMajor ShareholderSell425,800$0.17$72,386.00View SEC Filing  
2/11/2014Robert MelamedeMajor ShareholderSell779,200$0.19$148,048.00View SEC Filing  
2/6/2014Robert MelamedeMajor ShareholderSell473,300$0.25$118,325.00View SEC Filing  
2/4/2014Robert MelamedeMajor ShareholderSell659,700$0.19$125,343.00View SEC Filing  
1/30/2014Robert MelamedeMajor ShareholderSell600,200$0.19$114,038.00View SEC Filing  
1/27/2014Robert MelamedeMajor ShareholderSell525,000$0.14$73,500.00View SEC Filing  
1/22/2014Robert MelamedeMajor ShareholderSell476,500$0.11$52,415.00View SEC Filing  
1/16/2014Robert MelamedeMajor ShareholderSell425,800$0.10$42,580.00View SEC Filing  
1/13/2014Robert MelamedeMajor ShareholderSell248,800$0.12$29,856.00View SEC Filing  
1/9/2014Robert MelamedeMajor ShareholderSell170,200$0.13$22,126.00View SEC Filing  
1/7/2014Robert MelamedeMajor ShareholderSell132,200$0.07$9,254.00View SEC Filing  
1/3/2014Robert MelamedeMajor ShareholderSell83,300$0.07$5,831.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cannabis Science (OTCMKTS CBIS) News Headlines

Source:
DateHeadline
Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Marys Medicinals Cannabis Products to ...Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary's Medicinals Cannabis Products to ...
www.prnewswire.com - May 27 at 5:51 PM
2018 Global Health Catalyst Summit at Harvard Medical School is Streaming Live Now; Watch CBIS Executives ...2018 Global Health Catalyst Summit at Harvard Medical School is Streaming Live Now; Watch CBIS Executives ...
globenewswire.com - May 27 at 5:51 PM
2018 Global Health Catalyst Summit at Harvard Medical School is Streaming Live Now; Watch CBIS Executives Present Live2018 Global Health Catalyst Summit at Harvard Medical School is Streaming Live Now; Watch CBIS Executives Present Live
finance.yahoo.com - May 25 at 5:41 PM
Cannabis Leaf (PCFP) Apotheca Biosciences Provides Corporate Update Solving Opioid Addiction is Our First PriorityCannabis Leaf (PCFP) Apotheca Biosciences Provides Corporate Update Solving Opioid Addiction is Our First Priority
www.nasdaq.com - May 23 at 5:27 PM
Can Massachusetts become a leader in marijuana research?Can Massachusetts become a leader in marijuana research?
www.bizjournals.com - May 15 at 5:41 PM
Green Flower Responds to YouTubes Removal of Cannabis-based ContentGreen Flower Responds to YouTube's Removal of Cannabis-based Content
www.prnewswire.com - May 15 at 5:41 PM
Cannabis Science President & CEO Mr. Raymond C. Dabney Awarded The 2018 Harvard Global Health Catalyst ...Cannabis Science President & CEO Mr. Raymond C. Dabney Awarded The 2018 Harvard Global Health Catalyst ...
globenewswire.com - May 15 at 5:41 PM
Cannabis Science President & CEO Mr. Raymond C. Dabney Awarded The 2018 Harvard Global Health Catalyst Industry Leader Award May 25-27th at Harvard Medical School, Boston, MACannabis Science President & CEO Mr. Raymond C. Dabney Awarded The 2018 Harvard Global Health Catalyst Industry Leader Award May 25-27th at Harvard Medical School, Boston, MA
finance.yahoo.com - May 14 at 8:41 AM
Veritas Pharma Provides Comment on Canadian Senate Recommendation for a One-Year Deferment Legalizing ...Veritas Pharma Provides Comment on Canadian Senate Recommendation for a One-Year Deferment Legalizing ...
globenewswire.com - May 10 at 5:45 PM
Cannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of CancersCannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of Cancers
finance.yahoo.com - May 1 at 8:35 AM
Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science ...Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science ...
globenewswire.com - April 29 at 6:32 PM
Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’
finance.yahoo.com - April 27 at 5:09 PM
Cannabis Science is Proud to Announce 4/20 Success! Opening of the First CBIS Cali Rx Location on Ventura Blvd, in ...Cannabis Science is Proud to Announce 4/20 Success! Opening of the First CBIS Cali Rx Location on Ventura Blvd, in ...
globenewswire.com - April 23 at 5:06 PM
Cannabis Science is Proud to Announce 4/20 Success! Opening of the First CBIS Cali Rx Location on Ventura Blvd, in Sherman Oaks, CaliforniaCannabis Science is Proud to Announce 4/20 Success! Opening of the First CBIS Cali Rx Location on Ventura Blvd, in Sherman Oaks, California
finance.yahoo.com - April 23 at 8:22 AM
Universities meet growing demand with Weed 101Universities meet growing demand with Weed 101
www.cnn.com - April 22 at 6:27 PM
Heres What We Know About Marijuanas Health Benefits and Risks This 4/20Here's What We Know About Marijuana's Health Benefits and Risks This 4/20
fortune.com - April 22 at 6:27 PM
Photos: High science meets cannabis commerce at San Jose conferencePhotos: High science meets cannabis commerce at San Jose conference
www.bizjournals.com - April 22 at 6:27 PM
Evolab Alchemy Wins Best Vape Cartridge at 2018 Terpenes & Testing World ConferenceEvolab Alchemy Wins 'Best Vape Cartridge' at 2018 Terpenes & Testing World Conference
www.prnewswire.com - April 12 at 5:27 PM
Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County ...Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County ...
globenewswire.com - April 12 at 5:27 PM
Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All MultiplyCannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All Multiply
finance.yahoo.com - April 10 at 8:39 AM
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Companys ...CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company's ...
globenewswire.com - March 25 at 6:09 PM
UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Companys Research on the ...UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company's Research on the ...
globenewswire.com - March 25 at 6:09 PM
Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27000 Sq. Ft., Bottling Manufacturing Facility for ... - GlobeNewswire (press release)Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27000 Sq. Ft., Bottling Manufacturing Facility for ... - GlobeNewswire (press release)
globenewswire.com - March 19 at 8:33 AM
Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bottling Manufacturing Facility for Various Bottled Waters, Energy Drinks, Vitamin Shots, Tincture Bottles, Sprays, and Various Sized Food ContainersCannabis Science Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bottling Manufacturing Facility for Various Bottled Waters, Energy Drinks, Vitamin Shots, Tincture Bottles, Sprays, and Various Sized Food Containers
finance.yahoo.com - March 19 at 8:33 AM
Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol ... - GlobeNewswire (press release)Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol ... - GlobeNewswire (press release)
globenewswire.com - March 14 at 6:54 PM
Crown Baus Announces Acquisition of Cannabia, the Worlds First Cannabis Alcoholic Beverage; Will Partner With ... - GlobeNewswire (press release)Crown Baus Announces Acquisition of Cannabia, the World's First Cannabis Alcoholic Beverage; Will Partner With ... - GlobeNewswire (press release)
globenewswire.com - March 14 at 6:54 PM
Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol Versions of Crown Baus’ Newly Acquired Cannabia, The World’s First Cannabis BeerCannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol Versions of Crown Baus’ Newly Acquired Cannabia, The World’s First Cannabis Beer
finance.yahoo.com - March 14 at 6:54 PM
Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing ... - GlobeNewswire (press release)Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing ... - GlobeNewswire (press release)
globenewswire.com - March 6 at 8:26 AM
Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City ApprovalsCannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City Approvals
finance.yahoo.com - March 5 at 5:43 PM
Cannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana Social ... - GlobeNewswire (press release)Cannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana Social ... - GlobeNewswire (press release)
globenewswire.com - March 1 at 8:24 AM
Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles ... - GlobeNewswire (press release)Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles ... - GlobeNewswire (press release)
globenewswire.com - February 23 at 8:34 AM
Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization OptionsCannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization Options
finance.yahoo.com - February 22 at 8:30 AM
Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of CancersCannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers
finance.yahoo.com - February 2 at 3:55 PM
Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based MedicinesCannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based Medicines
finance.yahoo.com - January 31 at 3:49 PM
Cannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand OpeningsCannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand Openings
finance.yahoo.com - January 30 at 3:50 PM
Cannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers JournalsCannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers Journals
finance.yahoo.com - January 18 at 10:34 AM
Crown Baus Capital (OTC: CBCA) Acquires Military Grade CryptoGraphic Secure Online Communications System; Cannabis Science (OTC: CBIS) Measures Asset Backed Blockchain CryptoCurrency Usage with CryptoGraphic Systems IntegrationCrown Baus Capital (OTC: CBCA) Acquires Military Grade CryptoGraphic Secure Online Communications System; Cannabis Science (OTC: CBIS) Measures Asset Backed Blockchain CryptoCurrency Usage with CryptoGraphic Systems Integration
finance.yahoo.com - January 16 at 5:08 PM
Insider Selling: Cannabis Science Inc (CBIS) CFO Sells 193,626 Shares of StockInsider Selling: Cannabis Science Inc (CBIS) CFO Sells 193,626 Shares of Stock
www.americanbankingnews.com - January 13 at 12:14 AM
Cannabis Science, Expanding its Dispensary Operation and BlockchainCannabis Science, Expanding its Dispensary Operation and Blockchain
finance.yahoo.com - January 9 at 9:41 AM
Cannabis Science Has US Federal Government Clearance that Changes the Industry, Access to Federal Government ... - GlobeNewswire (press release)Cannabis Science Has US Federal Government Clearance that Changes the Industry, Access to Federal Government ... - GlobeNewswire (press release)
globenewswire.com - January 5 at 4:56 PM
Data Reveals Legal Cannabis Industry Projected to Grow - PR Newswire (press release)Data Reveals Legal Cannabis Industry Projected to Grow - PR Newswire (press release)
www.prnewswire.com - January 4 at 9:38 AM
Cannabis Science Inc (CBIS) COO Robert James Kane Sells 200,000 Shares of StockCannabis Science Inc (CBIS) COO Robert James Kane Sells 200,000 Shares of Stock
www.americanbankingnews.com - January 3 at 9:52 PM
Cannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO ... - GlobeNewswire (press release)Cannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO ... - GlobeNewswire (press release)
globenewswire.com - January 3 at 8:52 AM
Cannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO Growth While Adding Strength to its Pharmacy Openings and Pharmaceutical Drug Development ProgramsCannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO Growth While Adding Strength to its Pharmacy Openings and Pharmaceutical Drug Development Programs
finance.yahoo.com - January 3 at 8:52 AM
Cannabis Science Inc (CBIS) COO Sells $20,000.00 in StockCannabis Science Inc (CBIS) COO Sells $20,000.00 in Stock
www.americanbankingnews.com - December 29 at 7:00 PM
Cannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries ... - GlobeNewswire (press release)Cannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries ... - GlobeNewswire (press release)
globenewswire.com - December 29 at 10:12 AM
Cannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries in Los Angeles on Schedule to Open for the Much-Anticipated January 2018 California Market OpeningCannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries in Los Angeles on Schedule to Open for the Much-Anticipated January 2018 California Market Opening
finance.yahoo.com - December 28 at 3:49 PM
Cannabis Market Begins to Mature in Legal States - PR Newswire (press release)Cannabis Market Begins to Mature in Legal States - PR Newswire (press release)
www.prnewswire.com - December 28 at 8:31 AM
Cannabis Science Negotiates for Major Asset Backed Blockchain Crypto Currency with Cannabis and Many Other ... - GlobeNewswire (press release)Cannabis Science Negotiates for Major Asset Backed Blockchain Crypto Currency with Cannabis and Many Other ... - GlobeNewswire (press release)
globenewswire.com - December 22 at 9:00 PM
Cannabis Science Acquires Second PRE ICO Dispensary OTC ... - GlobeNewswire (press release)Cannabis Science Acquires Second PRE ICO Dispensary OTC ... - GlobeNewswire (press release)
globenewswire.com - December 22 at 9:00 PM

SEC Filings

Cannabis Science (OTCMKTS:CBIS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Cannabis Science (OTCMKTS CBIS) Stock Chart for Monday, May, 28, 2018

Loading chart…

This page was last updated on 5/28/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.